In a groundbreaking discovery, a collaborative effort between Greek and Turkish scientists has unveiled significant insights into the health benefits of extra virgin olive oil. This research, conducted with the support of the Sakellaropoulos organic olive groves in Sparta, has led to the development of an innovative laboratory method to identify the bioactive compound known as 3,3-dimethyl-1-butanol (DMB) in olive oil. This compound is believed to play a crucial role in combating harmful substances associated with cardiovascular diseases, such as atherosclerosis and inflammation.
Historically, references to DMB in scientific literature have been sparse and fragmented. Until now, no reliable methods had been published for safely determining DMB concentrations in extra virgin olive oil. The research team, led by Professor Apostolos Kyritsakis from the International University of Greece, has successfully confirmed the presence of DMB in olive oil through a scientifically validated method, marking a significant milestone in the field.
On June 30, 2025, the international team, which includes four Greeks, three Turks, and one Canadian, published their findings in the esteemed Journal of Food Bioactives. This study not only confirmed the existence of DMB in olive oil but also addressed two critical questions in the global scientific community: whether DMB is indeed present in olive oil and whether it enhances the oil’s value.
The research has also highlighted the vital role of the Sakellaropoulos olive groves, which have actively participated in clinical studies and research at renowned institutions such as Harvard and Yale. The findings indicate that samples from these groves exhibited the highest concentrations of DMB, with values reaching up to 11.4 mg/L in certain varieties.
Professor Kyritsakis emphasized the potential of DMB as a unique compound that may inhibit the action of enzymes responsible for producing harmful substances linked to various diseases. The research team is now focused on exploring how factors such as cultivation conditions, harvesting methods, and olive varieties influence DMB concentrations.
The implications of this study extend beyond mere academic interest. The findings suggest that DMB could lead to new strategies for preventing and treating cardiovascular diseases and other health issues. The research team is committed to further investigating the therapeutic potential of DMB, which has shown promise in preclinical studies for its ability to reduce harmful metabolites associated with cardiovascular health.
As the scientific community continues to explore the benefits of olive oil, this research opens new avenues for collaboration between Greek and Turkish researchers, highlighting the rich cultural heritage of olive cultivation and its significance in Mediterranean diets. The ongoing studies aim to deepen our understanding of the health benefits of olive oil, reinforcing its status as a functional food with high-quality attributes.
In summary, the discovery of DMB in olive oil represents a significant advancement in nutritional science, with the potential to reshape our understanding of the health benefits associated with this staple of Mediterranean cuisine. The research not only underscores the importance of olive oil in promoting health but also fosters international cooperation in scientific exploration.
